Treatment patterns and health care resource utilization among patients with relapsed/refractory systemic light chain amyloidosis.

Parameswaran HariHuamao Mark LinCarl V AscheJinma RenCandice YongKatarina LuptakovaDouglas V FallerVaishali Sanchorawala

Published in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2018)

RRAL amyloidosis is associated with high morbidity from target organ failure and mortality, which emphasizes the need for novel medications to improve care for patients with RRAL amyloidosis.

Keyphrases

multiple myeloma
healthcare
acute lymphoblastic leukemia
acute myeloid leukemia
palliative care
cardiovascular events
diffuse large b cell lymphoma
risk factors
quality improvement
hodgkin lymphoma
pain management
cardiovascular disease
health insurance